INVAC-1 Anti-Cancer hTERT DNA Immunotherapy

Clinical trial NCT02301754 · COMPLETED

Trial details

NCT number

NCT02301754

Sponsor

Invectys

Status

COMPLETED

Phase

Phase 1

Study type

INTERVENTIONAL

Start date

2014-11-01

Primary completion

2018-02-01

Enrollment

26

View on ClinicalTrials.gov